TSZY(002872)2024-10-29 11:08Revenue and Profit - Revenue for the third quarter was RMB 120.93 million, a 6.96% increase year-over-year[2] - Net profit attributable to shareholders for the third quarter was RMB 6.76 million, a 121.76% increase year-over-year[2] - Total operating income for the current period is 402.36 million yuan, a slight decrease from the previous period's 406.39 million yuan[14] - Net profit for the current period is a loss of 37.08 million yuan, compared to a loss of 82.19 million yuan in the previous period[15] - Basic earnings per share for the current period is -0.1143, compared to -0.2573 in the previous period[16] - Total comprehensive income for the current period is a loss of 37.08 million yuan, compared to a loss of 82.19 million yuan in the previous period[16] Assets and Liabilities - Total assets at the end of the reporting period were RMB 2.78 billion, a 1.25% decrease compared to the end of the previous year[2] - Total assets as of September 30, 2024, amounted to 2,775,680,001.16 yuan, slightly down from 2,810,906,249.36 yuan at the beginning of the period[13] - Total liabilities at the end of the reporting period are 715.75 million yuan, slightly higher than the previous period's 715.25 million yuan[14] - Total owner's equity at the end of the reporting period is 2.06 billion yuan, down from 2.10 billion yuan in the previous period[14] - The company's total liabilities and equity as of September 30, 2024, stood at 2,775,680,001.16 yuan[13] Investment and Financial Income - Investment income increased by 82,996.89% year-over-year due to the settlement of equity transfer with Chongqing Pharmaceutical (Group) Co., Ltd.[7] - Fair value change income increased by 189.36% year-over-year due to market price changes in other non-current financial assets[8] Expenses and Costs - Total operating costs for the current period are 461.24 million yuan, down from 501.01 million yuan in the previous period[14] - Sales expenses for the current period are 113.21 million yuan, a decrease from 139.29 million yuan in the previous period[15] - R&D expenses for the current period are 21.05 million yuan, down from 22.09 million yuan in the previous period[15] Cash Flow - Sales of goods and services received cash of 450,887,558.97, a slight increase from the previous period's 442,713,926.60[17] - Total cash inflows from operating activities were 474,670,478.13, down from 494,508,092.92 in the previous period[17] - Cash outflows for operating activities decreased to 470,436,585.22 from 576,392,557.12, resulting in a net cash flow from operating activities of 4,233,892.91, compared to a net outflow of 81,884,464.20 in the previous period[18] - Net cash flow from investing activities was 1,965,694.10, an improvement from the previous period's net outflow of 25,700,155.66[18] - Net cash flow from financing activities increased to 76,238,872.43 from 75,304,383.43 in the previous period[18] - The company's cash and cash equivalents increased by 82,438,459.44, compared to a decrease of 32,280,236.43 in the previous period[18] - The company's cash and cash equivalents at the end of the period were 242,843,594.52, slightly lower than the previous period's 245,970,173.64[18] Shareholders and Equity - The total number of ordinary shareholders at the end of the reporting period is 12,180[9] - Liu Qun, the largest shareholder, holds 32.89% of the shares, amounting to 104,590,532 shares[9] - Chongqing Yudian State-owned Assets Management Group holds 4.34% of the shares, totaling 13,792,255 shares[9] Monetary Funds and Receivables - The company's monetary funds increased to 243,032,690.69 yuan as of September 30, 2024, compared to 192,712,139.73 yuan at the beginning of the period[12] - Accounts receivable decreased to 135,835,105.77 yuan from 146,511,765.55 yuan at the beginning of the period[12] - Inventory decreased to 119,233,707.64 yuan from 136,219,070.11 yuan at the beginning of the period[13] Loans and Payables - Long-term loans increased by 121.87% compared to the beginning of the year due to new long-term borrowings[6] - Accounts payable decreased by 42.20% compared to the beginning of the year due to payments for materials, engineering, and equipment[6] - Taxes payable increased by 75.47% compared to the beginning of the year due to higher VAT payable[6] - Short-term borrowings decreased to 85,113,316.67 yuan from 114,139,997.23 yuan at the beginning of the period[13] - Accounts payable decreased to 44,706,699.77 yuan from 77,343,299.29 yuan at the beginning of the period[13] - Long-term loans at the end of the reporting period are 127.40 million yuan, up from 57.42 million yuan in the previous period[14] Impairment Losses - Credit impairment loss decreased by 36.12% year-over-year due to reduced impairment of receivables[8] - Asset impairment loss increased by 69.33% year-over-year due to increased inventory impairment[8] Other Financial Information - The company's third-quarter report was unaudited[19]